Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease

Keyphrases

• Blood Vessels 100%
• Chagas Disease 100%
• Plasminogen 100%
• Protein Biomarkers 100%
• Proteomic Signature 100%
• Proteome Signature 100%
• Disease Biomarker 100%
• Differentially Expressed Proteins 100%
• Serum Proteomics 100%
• Affinity Chromatography 50%
• Inflammation 50%
• Inflammatory Response 50%
• Etiology 50%
• Oxidative Stress 50%
• Lipid Metabolism 50%
• Cardiomyopathy 50%
• Aorta 50%
• Human Patients 50%
• Trypanosoma Cruzi (T. cruzi) 50%
• Prostaglandins 50%
• Acute Phase Response 50%
• Possible Mechanisms 50%
• Dysregulation 50%
• Stress-induced 50%
• Thrombosis 50%
• Platelet Aggregation 50%
• Angiogenesis 50%
• Arachidonic Acid 50%
• Serum Proteins 50%
• Complement Activation 50%
• Health Consequences 50%
• PF2D 50%
• Carbonyl 50%
• Two-dimensional Gel Electrophoresis 50%
• Phagocytes 50%
• Heart Function 50%
• Heart Disease 50%
• Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS) 50%
• Large Cohort 50%
• Low Abundance 50%
• LC-MS Analysis 50%
• Ingenuity Pathway Analysis 50%
• Muscle Damage 50%
• Cardiac muscle 50%
• Nodal Position 50%
• Enhanced Permeability 50%
• Biomarker Validation 50%
• Muscle Development 50%
• Pathophysiological Mechanisms 50%
• Vasodilatation 50%
• Functional Annotation 50%
• Cardiac Proteins 50%
• High Abundance 50%
• Proteome Databases 50%
• Vinculin 50%
• LC10 50%
• Endothelial Tubes 50%
• Prothrombin 50%
• Antioxidant Proteins 50%
• Myosin Light Chain 2 50%
• Myosin Heavy Chain 11 50%

Biochemistry, Genetics and Molecular Biology

• G Protein 33%
• Affinity Chromatography 33%